LGALS13 Human

Galectin-13 Human Recombinant
Cat. No.
BT10237
Source
Escherichia Coli.
Synonyms
Galactoside-binding soluble lectin 13, Galectin-13, Gal-13, Placental tissue protein 13, PP13, Placental protein 13, LGALS13, PLAC8, GAL13.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Human LGALS13 produced in E.Coli is a single, non-glycosylated polypeptide chain having a molecular mass of 16kDa. The LGALS13 also might appear as a homodimer, having a total Mw of 32kDa. LGALS13 is fused to a 6xHis tag at n-terminal and purified using standard chromatography techniques.

Product Specs

Introduction
Recombinant Galectin-13, produced in E. coli, is a peptide belonging to the galectin family. It is specifically found in the human placenta and possesses a carbohydrate recognition domain (CRD), characteristic of galectins. Elevated levels of Galectin-13 in the blood have been strongly linked to pregnancy complications like preeclampsia and HELLP syndrome. This protein has a molecular weight of 16 kDa.
Description
Recombinant Human LGALS13, expressed in E. coli, is a single polypeptide chain without glycosylation, with a molecular weight of 16 kDa. It can exist as a homodimer, resulting in a total molecular weight of 32 kDa. A 6xHis tag is fused to the N-terminal of LGALS13, and it undergoes purification using standard chromatography techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The LGALS13 protein solution is provided at a concentration of 0.5 mg/ml in 1xPBS buffer with a pH of 7.4.
Stability
For best results within 2-4 weeks, store the vial at 4°C. For longer-term storage, freeze at -20°C. Adding a carrier protein like 0.1% HSA or BSA is recommended for extended storage. Avoid repeated freezing and thawing cycles.
Purity
SDS-PAGE analysis confirms a purity level exceeding 90.0%.
Synonyms
Galactoside-binding soluble lectin 13, Galectin-13, Gal-13, Placental tissue protein 13, PP13, Placental protein 13, LGALS13, PLAC8, GAL13.
Source
Escherichia Coli.
Amino Acid Sequence

MSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDM                   DEDSDIAFRFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGK

QFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN

Product Science Overview

Introduction to Galectins

Galectins are a family of carbohydrate-binding proteins that play crucial roles in various physiological and pathological processes. They are characterized by their affinity for β-galactoside residues and are involved in inflammation, immune responses, cell migration, autophagy, and signaling . Galectins are synthesized as cytosolic proteins and can interact with both carbohydrate and non-carbohydrate binding partners .

Discovery and Structure

Galectins were initially discovered due to their galactoside-binding activity. They were defined as a protein family based on conserved β-galactoside-binding sites within their characteristic carbohydrate recognition domains (CRDs), which are approximately 130 amino acids long . The galectin family has evolved through tandem and en-mass genome duplications, resulting in over 15 known vertebrate galectins .

Galectin-13

Galectin-13, also known as placental protein 13 (PP13), is a member of the galectin family. It is predominantly expressed in the placenta and has been implicated in various reproductive processes. Galectin-13 is involved in the regulation of immune responses at the maternal-fetal interface, promoting immune tolerance and contributing to successful pregnancy outcomes .

Functions and Mechanisms

Galectin-13 has several important functions:

  1. Immune Modulation: Galectin-13 modulates immune responses by interacting with immune cells and influencing cytokine production. It promotes the differentiation of regulatory T cells and suppresses the activation of effector T cells, thereby contributing to immune tolerance during pregnancy .
  2. Angiogenesis: Galectin-13 plays a role in angiogenesis, the formation of new blood vessels, which is essential for placental development and function. It promotes the proliferation and migration of endothelial cells, facilitating the establishment of a functional placental vasculature .
  3. Apoptosis: Galectin-13 can induce apoptosis, or programmed cell death, in certain cell types. This function is important for maintaining tissue homeostasis and preventing excessive inflammation .
Recombinant Galectin-13

Recombinant Galectin-13 is produced using recombinant DNA technology, which involves inserting the gene encoding Galectin-13 into a suitable expression system, such as bacteria or mammalian cells. This allows for the large-scale production of Galectin-13 for research and therapeutic purposes .

Applications

Recombinant Galectin-13 has several potential applications:

  1. Research: Recombinant Galectin-13 is used in research to study its functions and mechanisms in various biological processes. It serves as a valuable tool for investigating the role of galectins in immune regulation, angiogenesis, and apoptosis .
  2. Therapeutics: Due to its immunomodulatory and angiogenic properties, recombinant Galectin-13 holds promise as a therapeutic agent for conditions such as preeclampsia, a pregnancy complication characterized by high blood pressure and organ damage .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.